Interestingly, in our cohort, patients with ANGPT2 levels higher than 5,000 pg/mL at admission showed both higher counts of TF+ EVs from endothelial cells, as well as higher TF procoagulant activity, reinforcing the concept that ANGPT2 could be associated with TF expression in COVID-19. This evidence concerns the gene TF and COVID-19.